|Bid||32.00 x 900|
|Ask||41.76 x 800|
|Day's Range||34.10 - 36.60|
|52 Week Range||25.92 - 50.26|
|Beta (5Y Monthly)||1.24|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
IHG, NNN, PRMW, RGNX, and WW have been added to the Zacks Rank #5 (Strong Sell) List on March 24, 2021
A look at the shareholders of REGENXBIO Inc. ( NASDAQ:RGNX ) can tell us which group is most powerful. Insiders often...
With us are Ken Mills, REGENXBIO's President and Chief Executive Officer, Dr. Steve Pakola, our Chief Medical Officer, Dr. Olivier Danos our Chief Scientific Officer, and Vit Vasista, our Chief Financial Officer. Earlier this afternoon, REGENXBIO released financial and operating results for the fourth quarter and full year ended December 31, 2020.